MILESTONE (MMD): The change in the position of Chief Executive Officer - raport 2
The Board of Directors of Milestone Medical Inc. (the „Company”, the „Issuer”) announces that the Board of Directors on December 18, 2017 adopted the resolution on the appointment of Leonard Osser for the position of Interim Chief Executive Officer to serve in such role until the appointment of a new Chief Executive Officer. The appointment of Mr. Osser becomes effective as of December 18, 2017. Mrs. Leslie Bernhard, who previously served as Interim Chief Executive Officer, resigned from the position of Interim Chief Executive Officer effective as of the end of the day of December 18, 2017.
According to the best knowledge of the Board of Directors of Issuer, Mr. Leonard Osser does perform the activities outside the Issuer, where such activities are significant for the Issuer. Mr. Leonard Osser is Chief Executive Officer of Milestone Scientific Inc., the majority shareholder of Milestone Medical Inc.
Moreover, according to the best knowledge of the Board of Directors of Issuer, Mr. Leonard Osser:
- is not a partner in a competitive civil partnership or commercial law company
- is not a member of a body of competitive a joint-stock company
- is not a member of a body of any competitive legal person
- has no record in the register of insolvent debtors.
The personal form of Mr. Leonard Osser has been attached to this report.
Legal basis: Section 3.1.7 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”.
Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer
